跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CEFTRIAXONE KABI POWDER FOR SOLUTION FOR INFUSION 2.0G/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
CEFTRIAXONE KABI POWDER FOR SOLUTION FOR INFUSION 2.0G/VIAL
Approved
THERAPEUTIC
CEFTRIAXONE KABI POWDER FOR SOLUTION FOR INFUSION 2.0G/VIAL
LABESFAL - LABORATORIOS ALMIRO, SA (PORTUGAL)
🇸🇬 Health Sciences Authority
Approval Date
May 20, 2016
Approval ID
41ef1efdbf6a1073
Company
LABESFAL - LABORATORIOS ALMIRO, SA (PORTUGAL)
Type
Therapeutic
Approval Details
Approval Id
41ef1efdbf6a1073
Drug Name
CEFTRIAXONE KABI POWDER FOR SOLUTION FOR INFUSION 2.0G/VIAL
Product Name
CEFTRIAXONE KABI POWDER FOR SOLUTION FOR INFUSION 2.0G/VIAL
Approval Number
SIN15009P
Approval Date
2016-05-20
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J01DD04
Atc Item Name
ceftriaxone
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Active Ingredients
Ceftriaxone Sodium 3.5 H2O 2386mg eqv Ceftriaxone
2000mg/bottle
Ceftriaxone Sodium 3.5 H2O 2386mg eqv Ceftriaxone
2000mg/bottle
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 20, 2016
Approval ID
41ef1efdbf6a1073
Type
Therapeutic
Back to HSA Approvals
